[1]
|
Laragh, J.H. and Sealey, J.E. (2011) The Plasma Renin Test Reveals the Contribution of Body Sodium-Volume Content (V) and Renin Angiotensin (R) Vasoconstriction to Long-Term Blood Pressure. American Journal of Hypertension, 24, 1164-1180. https://doi.org/10.1038/ajh.2011.171
|
[2]
|
Hattangady, N.G., Olala, L.O., Bollag, W.B., et al. (2012) Acute and Chronic Regulation of Aldosterone Production. Molecular and Cellular Endocrinology, 350, 151-162. https://doi.org/10.1016/j.mce.2011.07.034
|
[3]
|
Sowers, J.R., Whaley-Connell, A. and Epstein, M. (2009) Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hyper-tension. Annals of Internal Medicine, 150, 776-783. https://doi.org/10.7326/0003-4819-150-11-200906020-00005
|
[4]
|
Sztechman, D., Czarzasta, K., Cud-noch-Jedrzejewska, A., Szczepanska-Sadowska, E. and Zera, T. (2018) Aldosterone and Mineralocorticoid Receptors in Regulation of the Cardiovascular System and Pathological Remodelling of the Heart and Arteries. Journal of Physiology and Pharmacology, 69, 829-845.
|
[5]
|
Catena, C., Colussi, G. and Sechi, L.A. (2013) Aldosterone, Organ Damage and Dietary Salt. Clinical and Experimental Pharmacology and Physiology, 40, 922-928. https://doi.org/10.1111/1440-1681.12145
|
[6]
|
Gan, L., Li, N.F., Mulalibieke, H., et al. (2022) Higher Plasma Al-dosterone Is Associated with Increased Risk of Cardiovascular Events in Hypertensive Patients with Suspected OSA: UROSAH Data. Frontiers in Endocrinology (Lausanne), 13, Article ID: 1017177. https://doi.org/10.3389/fendo.2022.1017177
|
[7]
|
Tomaschitz, A., Pilz, S., Ritz, E., Meinitzer, A., Boehm, B.O. and Marz, W. (2010) Plasmaaldosterone Levels Are Associated with Increased Cardiovascular Mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. European Heart Journal, 31, 1237-1247. https://doi.org/10.1093/eurheartj/ehq019
|
[8]
|
Joseph, J.J., Echouffo-Tcheugui, J.B., Kalyani, R.R., Yeh, H.C., Bertoni, A.G., Effoe, V.S., et al. (2017) Aldosterone, Renin, Cardiovascular Events, and All-Cause Mortality among Af-rican Americans: The Jackson Heart Study. JACC: Heart Failure, 5, 642-651. https://doi.org/10.1016/j.jchf.2017.05.012
|
[9]
|
Briet, M. and Schiffrin, E.L. (2013) Vascular Actions of Aldoste-rone. Journal of Vascular Research, 50, 89-99.
https://doi.org/10.1159/000345243
|
[10]
|
Fiebeler, A., Muller, D.N., Shagdarsuren, E. and Luft, F.C. (2007) Aldos-terone, Mineralocorticoid Receptors, and Vascular Inflammation. Current Opinion in Nephrology and Hypertension, 16, 134-142.
https://doi.org/10.1097/MNH.0b013e32801245bb
|
[11]
|
Blasi, E.R., Rocha, R., Rudolph, A.E., Blomme, E.A.G., Polly, M.L. and McMahon, E.G. (2003) Aldosterone/Salt Induces Renal Inflammation and Fibrosis in Hypertensive Rats. Kidney International, 63, 1791-1800.
https://doi.org/10.1046/j.1523-1755.2003.00929.x
|
[12]
|
Del Vecchio, L., Procaccio, M., Vigano, S. and Cusi, D. (2007) Mechanisms of Disease: The Role of Aldosterone in Kidney Damage and Clinical Benefits of Its Blockade. Na-ture Clinical Practice Nephrology, 3, 42-49.
https://doi.org/10.1038/ncpneph0362
|
[13]
|
Bauersachs, J., Jaisser, F. and Toto, R. (2015) Mineralocorticoid Recep-tor Activation and Mineralocorticoid Receptor Antagonist Treatment in Cardiac and Renal Diseases. Hypertension, 65, 257-263.
https://doi.org/10.1161/HYPERTENSIONAHA.114.04488
|
[14]
|
Cosimato, C., Agoritsas, T. and Mavrakanas, T.A. (2021) Mineralocorticoid Receptor Antagonists in Patients with Chronic Kidney Disease. Pharmacology & Therapeutics, 219, Article ID: 107701.
https://doi.org/10.1016/j.pharmthera.2020.107701
|
[15]
|
Kesireddy, V., Tan, Y., Kline, D., Brock, G., Odei, J.B., Kluwe, B., Effoe, V.S., et al. (2019) The Association of Life’s Simple 7 with Aldosterone among African Americans in the Jackson Heart Study. Nutrients, 11, Article No. 955.
https://doi.org/10.3390/nu11050955
|
[16]
|
Emanuele, E., Geroldi, D., Minoretti, P., et al. (2005) Increased Plasma Aldosterone in Patients with Clinical Depression. Archives of Medical Research, 36, 544-548. https://doi.org/10.1016/j.arcmed.2005.03.046
|
[17]
|
Kerstens, M.N., Kobold, A.C., Volmer, M., Koerts, J., Sluiter, W.J. and Dullaart, R.P. (2011) Reference Values for Aldosterone-Renin Ratios in Normotensive Individuals and Effect of Changes in Dietary Sodium Consumption. Clinical Chemistry, 57, 1607-1611. https://doi.org/10.1373/clinchem.2011.165662
|
[18]
|
Nanba, K., Vaidya, A., Williams, G.H., et al. (2017) Age-Related Autonomous Aldosteronism. Circulation, 136, 347-355. https://doi.org/10.1161/CIRCULATIONAHA.117.028201
|
[19]
|
Kathiresan, S., Larson, M.G., Benjamin, E.J., et al. (2005) Clinical and Genetic Correlates of Serum Aldosterone in the Community: The Framingham Heart Study. Ameri-can Journal of Hypertension, 18, 657-665.
https://doi.org/10.1016/j.amjhyper.2004.12.005
|
[20]
|
Faulkner, J.L., Harwood, D., Kennard, S., et al. (2021) Die-tary Sodium Restriction Sex Specifically Impairs Endothelial Function via Mineralocorticoid Receptor-Dependent Reduc-tion in NO Bioavailability in Balb/C Mice. The American Journal of Physiology-Heart and Circulatory Physiology, 320, H211-H220.
https://doi.org/10.1152/ajpheart.00413.2020
|
[21]
|
Faulkner, J.L., Lluch, E., Kennard, S., et al. (2020) Selective De-letion of Endothelial Mineralocorticoid Receptor Protects from Vascular Dysfunction in Sodium-Restricted Female Mice. Biology of Sex Differences, 11, Article No. 64.
https://doi.org/10.1186/s13293-020-00340-5
|
[22]
|
Caroccia, B., Seccia, T.M., Campos, A.G., Gioco, F., Kup-pusamy, M., Ceolotto, G., et al. (2014) GPER-1 and Estrogen Receptor-Beta Ligands Modulate Aldosterone Synthesis. Endocrinology, 155, 4296-4304.
https://doi.org/10.1210/en.2014-1416
|
[23]
|
Roger, V.L., Go, A.S., Lloyd-Jones, D.M., et al. (2012) Heart Disease and Stroke Statistics-2012 Update: A Report from the American Heart Association. Circulation, 125, e2-e220.
|
[24]
|
Clark, B.A., Elahi, D. and Epstein, F.H. (1990) The Influence of Gender, Age, and the Menstrual Cycle on Plasma Atrial Natriuretic Peptide. The Journal of Clinical Endocrinology & Metabolism, 70, 349-352.
https://doi.org/10.1210/jcem-70-2-349
|
[25]
|
Kidambi, S., Kotchen, J.M., Grim, C.E., Raff, H., Mao, J., Singh, R.J. and Kotchen, T.A. (2007) Association of Adrenal Steroids with Hypertension and the Metabolic Syndrome in Blacks. Hypertension, 49, 704-711.
https://doi.org/10.1161/01.HYP.0000253258.36141.c7
|
[26]
|
Bochud, M., Nussberger, J., Bovet, P., Maillard, M.R., Elston, R.C., Paccaud, F., Shamlaye, C. and Burnier, M. (2006) Plasma Aldosterone Is Independently Associated with the Metabolic Syndrome. Hypertension, 48, 239-245.
https://doi.org/10.1161/01.HYP.0000231338.41548.fc
|
[27]
|
Matsubara, M., Maruoka, S. and Katayose, S. (2002) Inverse Relationship between Plasma Adiponectin and Leptinconcentrations in Normal-Weight and Obese Women. Eu-ropean Journal of Endocrinology, 147, 173-180.
https://doi.org/10.1530/eje.0.1470173
|
[28]
|
Ghandehari, H., Le, V., Kamal-Bahl, S., Bassin, S.L. and Wong, N.D. (2009) Abdominal Obesity and the Spectrum of Global Cardiometabolic Risks in US Adults. International Journal of Obesity (London), 33, 239-248.
https://doi.org/10.1038/ijo.2008.252
|
[29]
|
Briones, A.M., Nguyen Dinh Cat, A., Callera, G.E., Yogi, A., Burger, D., He, Y., et al. (2012) Adipocytes Produce Aldosterone through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus-Associated Obesity and Vascular Dysfunction. Hypertension, 59, 1069-1078.
https://doi.org/10.1161/HYPERTENSIONAHA.111.190223
|
[30]
|
Ehrhart-Bornstein, M., Lamounier-Zepter, V., Schraven, A., et al. (2003) Human Adipocytes Secrete Mineralocorticoid-Releasing Factors. Proceedings of the National Academy of Sciences of the United States of America, 100, 14211- 14216. https://doi.org/10.1073/pnas.2336140100
|
[31]
|
Huby, A.-C., Antonova, G., Groenendyk, J., Gomez-Sanchez, C.E., Bollag, W.B., Filosa, J.A. and De Chantemèle, E.J.B. (2015) Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis. Circulation, 132, 2134-2145.
https://doi.org/10.1161/CIRCULATIONAHA.115.018226
|
[32]
|
Engeli, S., Bohnke, J., Gorzelniak, K., Janke, J., Schling, P., Bader, M., Luft, F.C., Sharma, A.M. and Bohnke, J. (2005) Weight Loss and the Ren-in-Angiotensin-Aldosterone System. Hypertension, 45, 356-362.
https://doi.org/10.1161/01.HYP.0000154361.47683.d3
|
[33]
|
Baer, L. and Radichevich, I. (1995) Cigarette Smoking in Hypertensive Patients Blood Pressure and Endocrine Responses. The American Journal of Medicine, 78, 564-568. https://doi.org/10.1016/0002-9343(85)90396-1
|
[34]
|
Laustiola, K.E., Lassila, R. and Nurmi, A.-K. (1988) Enhanced Activation of the Renin-Angiotensin-Aldosterone System in Chronic Cigarette Smokers: A Study of Monozygotic Twin Pairs Discordant for Smoking. Clinical Pharmacology & Therapeutics, 44, 426-430. https://doi.org/10.1038/clpt.1988.175
|
[35]
|
Delgado, G.E., Siekmeier, R., Krämer, B.K., Grübler, M.R., Tomaschitz, A., März, W. and Kleber, M.E. (2016) The Renin-Angiotensin-Aldosterone System in Smokers and Non-Smokers of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. In: Pokorski, M., Ed., Pulmonary Infection and Inflam-mation, Springer, Berlin, 75-82.
https://doi.org/10.1007/5584_2016_39
|
[36]
|
Saijonmaa, O., Nyman, T. and Fyhrquist, F. (2005) Regulation of An-giotensin-Converting Enzyme Production by Nicotine in Human Endothelial Cells. The American Journal of Physiolo-gy-Heart and Circulatory Physiology, 289, H2000- H2004. https://doi.org/10.1152/ajpheart.01238.2004
|
[37]
|
Ljungberg, L.U. and Persson, K. (2008) Effect of Nicotine and Nicotine Metabolites on Angiotensin-Converting Enzyme in Human Endothelial Cells. Endothelium, 15, 239-245. https://doi.org/10.1080/10623320802487627
|
[38]
|
Toering, T.J., Gant, C.M., Visser, F.W., van der Graaf, A.M., Laverman, G.D., Jan Danser, A.H., Faas, M.M., Navis, G. and Lely, A.T. (2017) Gender Differences in Renin Angio-tensin Aldosterone System Affect Extra Cellular Volume in Healthy Subjects. American Journal of Physiology-Renal Physiology, 314, F873-F878.
https://doi.org/10.1152/ajprenal.00109.2017
|
[39]
|
Shukri, M.Z., Tan, J.W., Manosroi, W., Pojoga, L.H., Rivera, A., Williams, J.S., Seely, E.W., Adler, G.K., Jaffe, I.Z., Karas, R.H., et al. (2018) Biological Sex Modulates the Adrenal and Blood Pressure Responses to Angiotensin II. Hypertension, 71, 1083-1090. https://doi.org/10.1161/HYPERTENSIONAHA.117.11087
|
[40]
|
Sobrino, P., Ojeda, M.L., Nogales, F., et al. (2019) Binge Drinking Affects Kidney Function, Osmotic Balance, Aldosterone Levels, and Arterial Pressure in Ado-lescent Rats: The Potential Hypotensive Effect of Selenium Mediated by Improvements in Oxidative Balance. Hyperten-sion Research, 42, 1495-1506.
https://doi.org/10.1038/s41440-019-0265-z
|
[41]
|
Aoun, E.G., Jimenez, V.A., Vendruscolo, L.F., et al. (2018) A Relationship between the Aldosterone-Mineralocorticoid Receptor Pathway and Alcohol Drinking: Preliminary Transla-tional Findings across Rats, Monkeys and Humans. Molecular Psychiatry, 23, 1466-1473. https://doi.org/10.1038/mp.2017.97
|
[42]
|
Lékó András, H., McGinn, M.A. and Farokhnia, M. (2022) The Mineral-ocorticoid Receptor: An Emerging Pharmacotherapeutic Target for Alcohol Use Disorder? ACS Chemical Neuroscience, 13, 1832-1834.
https://doi.org/10.1021/acschemneuro.2c00326
|
[43]
|
Collier, S.R., Sandberg, K., Moody, A.M., Frechette, V., Cur-ry, C.D., Ji, H., Gowdar, R., Chaudhuri, D. and Meucci, M. (2015) Reduction of Plasma Aldosterone and Arterial Stiff-ness in Obese Pre- and Stage 1 Hypertensive Subjects after Aerobic Exercise. Journal of Human Hypertension, 29, 53-57. https://doi.org/10.1038/jhh.2014.33
|
[44]
|
Jones, J.M., Dowling, T.C., Park, J.-J., Phares, D.A., Park, J.-Y., Obisesan, T.O., Brown, M.D., Anderson, C.M.H. and Thwaites, D.T. (2007) Differential Aerobic Exercise-Induced Changes in Plasma Aldosterone between African Americans and Caucasians. Experimental Physiology, 92, 871-879. https://doi.org/10.1113/expphysiol.2007.037408
|
[45]
|
Goessler, K., Polito, M. and Cornelissen, V.A. (2016) Effect of Exercise Training on the Renin-Angiotensin-Aldosterone System in Healthy Individuals: A Systematic Review and Meta-Analysis. Hypertension Research, 39, 119-126.
https://doi.org/10.1038/hr.2015.100
|
[46]
|
Carroll, J.F., Convertino, V.A., Wood, C.E., Greves, J.E., Lowenthel, D.T. and Pollock, M.L. (1995) Effect of Training on Blood Volume and Plasma Hormone Concentrations in the Elderly. Medicine & Science in Sports & Exercise, 27, 79-84. https://doi.org/10.1249/00005768-199501000-00015
|
[47]
|
Waldman, B.M., Augustyniak, R.A., Chen, H. and Ros-si, N.F. (2017) Effects of Voluntary Exercise on Blood Pressure, Angiotensin II, Aldosterone, and Renal Function in Two-Kidney, One-Klip Hypertensive Rats. Integrated Blood Pressure Control, 10, 41-51. https://doi.org/10.2147/IBPC.S147122
|
[48]
|
Lee, D.-C., Pate, R.R., Lavie, C.J., Sui, X., Church, T.S. and Blair, S.N. (2014) Leisure-Time Running Reduces All- Cause and Cardiovascular Mortality Risk. Journal of the American College of Cardiology, 64, 472-481.
https://doi.org/10.1016/j.jacc.2014.04.058
|
[49]
|
Eckel, R.H., Jakicic, J.M., Ard, J.D., de Jesus, J.M., Houston Mil-ler, N., Hubbard, V.S., Lee, I.-M., et al. (2013) AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascu-lar Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guide-lines. Circulation, 129, S76-S99.
https://doi.org/10.1161/01.cir.0000437740.48606.d1
|
[50]
|
Pandey, A., Garg, S., Khunger, M., Darden, D., Ayers, C., Kumbhani, D.J., Mayo, H.G., de Lemos, J.A. and Berry, J.D. (2015) Dose-Response Relationship between Physical Activity and Risk of Heart Failure: A Meta-Analysis. Circulation, 132, 1786-1794. https://doi.org/10.1161/CIRCULATIONAHA.115.015853
|
[51]
|
Bell, E.J., Lutsey, P.L., Windham, B.G. and Fol-som, A.R. (2013) Physical Activity and Cardiovascular Disease in African Americans in Atherosclerosis Risk in Com-munities. Medicine & Science in Sports & Exercise, 45, 901-907.
https://doi.org/10.1249/MSS.0b013e31827d87ec
|
[52]
|
Huan, Y., DeLoach, S., Keith, S.W., Goodfriend, T.L. and Falkner, B. (2012) Aldosterone and Aldosterone: Renin Ratio Associations with Insulin Resistance and Blood Pressure in African Americans. Journal of the American Society of Hypertension, 6, 56-65. https://doi.org/10.1016/j.jash.2011.09.005
|
[53]
|
Saha, S., Graessler, J., Kopprasch, S. and Bornstein, S.R. (2012) Very-Low-Density Lipoprotein Mediates Transcriptional Regulation of Aldosterone Synthase in Human Adrenocortical Cells through Multiple Signaling Pathways. Cell and Tissue Research, 348, 71-80. https://doi.org/10.1007/s00441-012-1346-3
|
[54]
|
Xing, Y., Cohen, A., Rothblat, G., Sankaranarayanan, S., Weibel, G., Royer, L., Francone, O.L. and Rainey, W.E. (2011) Aldosterone Production in Human Adrenocortical Cells Is Stim-ulated by High-Density Lipoprotein 2 (HDL2) through Increased Expression of Aldosterone Synthase (CYP11B2). En-docrinology, 152, 751-763.
https://doi.org/10.1210/en.2010-1049
|
[55]
|
Baudrand, R., Pojoga, L.H., Vaidya, A., Garza, A.E., Vöhringer, P.A., Jeunemaitre, X., Hopkins, P.N., Yao, T.M., Williams, J., Adler, G.K., et al. (2015) Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects. Circulation, 132, 1825-1833. https://doi.org/10.1161/CIRCULATIONAHA.115.016759
|
[56]
|
Joseph, J.J., Echouffo-Tcheugui, J.B., Kalyani, R.R., Yeh, H.-C., Bertoni, A.G., Effoe, V.S., Casanova, R., Sims, M., Correa, A., Wu, W.-C., et al. (2016) Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study. The Journal of Clinical Endocrinology & Metabolism, 101, 1770-1778.
https://doi.org/10.1210/jc.2016-1002
|
[57]
|
Corry, D.B. and Tuck, M.L. (2003) The Effect of Aldosterone on Glu-cose Metabolism. Hypertension Research, 5, 106-109. https://doi.org/10.1007/s11906-003-0065-2
|
[58]
|
Underwood, P.C. and Adler, G.K. (2013) The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans. Current Hypertension Reports, 15, 59-70. https://doi.org/10.1007/s11906-012-0323-2
|
[59]
|
Guo, C., Ricchiuti, V., Lian, B.Q., Yao, T.M., Coutinho, P., Romero, J.R., Li, J., Williams, G.H. and Adler, J.K. (2008) Mineralocorticoid Receptor Blockade Reverses Obesi-ty-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-γ, and Proinflammatory Adipokines. Circulation, 7, 2253-2261.
https://doi.org/10.1161/CIRCULATIONAHA.107.748640
|
[60]
|
Ishii, M., Atarashi, K., Ikeda, T., Hirata, Y., Igari, T., Uehara, Y., et al. (1983) Role of the Aldosterone System in the Salt-Sensitivity of Patients with Benign Essential Hy-pertension. Japanese Heart Journal, 24, 79-90.
https://doi.org/10.1536/ihj.24.79
|
[61]
|
Kawarazaki, W. and Fujita, T. (2013) Aberrant Rac1-Mineralocorticoid Re-ceptor Pathways in Salt-Sensitive Hypertension. Clinical and Experimental Pharmacology and Physiology, 40, 929-936.
https://doi.org/10.1111/1440-1681.12177
|
[62]
|
Barrett, P.Q., Bollag, W.B., Isales, C.M., McCarthy, R.T. and Ras-mussen, H. (1989) Role of Calcium in Angiotensin II-Mediated Aldosterone Secretion. Endocrine Reviews, 10, 1-22. https://doi.org/10.1210/edrv-10-4-496
|
[63]
|
Ganguly, A. and Davis, J.S. (1994) Role of Calcium and Other Media-tors in Aldosterone Secretion from the Adrenal Glomerulosa Cells. Pharmacological Reviews, 46, 417-447.
|
[64]
|
Capponi, A.M., Lew, P.D., Jornot, L. and Vallotton, M.B. (1984) Correlation between Cytosolic Free Ca2+ and Aldosterone Production in Bovine Adrenal Glomerulosa Cells. Evidence for a Difference in the Mode of Action of Angiotensin II and Potassium. Journal of Biological Chemistry, 259, 8863-8869.
https://doi.org/10.1016/S0021-9258(17)47233-4
|
[65]
|
Hunyady, L., Baukal, A.J., Bor, M., Ely, J.A. and Catt, K.J. (1990) Regulation of 1,2-Diacylglycerol Production by Angiotensin-II in Bovine Adrenal Glomerulosa Cells. Endocri-nology, 126, 1001-1008.
https://doi.org/10.1210/endo-126-2-1001
|
[66]
|
Kojima, I., Kojima, K. and Rasmussen, H. (1985) Intracellular Cal-cium and Adenosine 3’,5’-Cyclic Monophosphate as Mediators of Potassium-Induced Aldosterone Secretion. Biochemi-cal Journal, 228, 69-76.
https://doi.org/10.1042/bj2280069
|
[67]
|
Häfner, S., Baumert, J., Emeny, R.T., et al. (2012) To Live Alone and to Be Depressed, an Alarming Combination for the Renin-Angiotensin-Aldosterone-System (RAAS). Psychoneuroendocri-nology, 37, 230-237.
https://doi.org/10.1016/j.psyneuen.2011.06.007
|
[68]
|
Segeda, V., Izakova, L., Hlavacova, N., Bednarova, A. and Jezova, D. (2017) Aldosterone Concentrations in Saliva Reflect the Duration and Severity of Depressive Episode in a Sex Dependent Manner. Journal of Psychiatric Research, 91, 164-168. https://doi.org/10.1016/j.jpsychires.2017.04.011
|
[69]
|
Murck, H., Schlageter, L., Schneider, A., et al. (2020) The Potential Pathophysiological Role of Aldosterone and the Mineralocorticoid Receptor in Anxiety and Depres-sion—Lessons from Primary Aldosteronism. Journal of Psychiatric Research, 130, 82-88. https://doi.org/10.1016/j.jpsychires.2020.07.006
|
[70]
|
Hlavacova, N., Wes, P.D., Ondrejcakova, M., et al. (2012) Subchronic Treatment with Aldosterone Induces Depression-Like Behaviours and Gene Expression Changes Relevant to Major Depressive Disorder. International Journal of Neuropsychopharmacology, 15, 247-265. https://doi.org/10.1017/S1461145711000368
|
[71]
|
Hlavacova, N. and Jezova, D. (2008) Chronic Treatment with the Mineralocorticoid Hormone Aldosterone Results in Increased Anxiety-Like Behavior. Hormones and Behavior, 54, 90-97. https://doi.org/10.1016/j.yhbeh.2008.02.004
|
[72]
|
Bay-Richter, C., Hallberg, L., Ventorp, F., Janelidze, S. and Brundin, L. (2012) Aldosterone Synergizes with Peripheral Inflammation to Induce Brain IL-1beta Expression and Depressive-Like Effects. Cytokine, 60, 749-754.
https://doi.org/10.1016/j.cyto.2012.08.016
|